Baby KJ's gene-editing drug cost $1.65M to make, Fyodor Urnov says

Summary

The world's first therapy designed to fix a patient's unique genetic mutation cost $1.65 million to make, according to a key project facilitator speaking at a rare disease conference in Oxford.